Company No:
Contents
| Note | 2024 | |
| £ | ||
| Fixed assets | ||
| Intangible assets | 3 |
|
| Investments | 4 |
|
| 347,389 | ||
| Current assets | ||
| Debtors | 5 |
|
| Cash at bank and in hand |
|
|
| 21,115 | ||
| Creditors: amounts falling due within one year | 6 | (
|
| Net current liabilities | (361,411) | |
| Total assets less current liabilities | (14,022) | |
| Provision for liabilities | (
|
|
| Net liabilities | (
|
|
| Capital and reserves | ||
| Called-up share capital | 7 |
|
| Share premium account |
|
|
| Profit and loss account | (
|
|
| Total shareholders' deficit | (
|
Directors' responsibilities:
The financial statements of District Health Limited (registered number:
|
Mr C J Addison
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.
District Health Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is C/O Francis Clark Llp Unit 18, 23 Melville Building East, Royal William Yard, Plymouth, PL1 3GW, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors note that the business has net liabilities of £15,651. The Company is supported through loans from the directors. The directors have confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the directors will continue to support the Company. Given the current position, the directors believe that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Group accounts exemption s399
The Company has taken advantage of the exemption in section 399 of the Companies Act 2006 not to prepare consolidated accounts, because the group it heads qualifies as small. The financial statements present information about the Company as an individual entity only.
During the current financial period, the company changed its accounting reference date from 31 January to 31 December in order to align with other group companies. As a result, the current period covers 11 months, from 1 February 2024 to 31 December 2024. The comparative figures presented relate to a full 12-month period and are therefore not directly comparable.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.
| Computer software |
|
Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.
Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.
Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.
Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.
Other basic financial liabilities are measured at amortised cost.
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
| 2024 | |
| Number | |
| Monthly average number of persons employed by the Company during the period, including directors |
|
| Computer software | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 January 2024 |
|
|
|
| Additions |
|
|
|
| At 31 December 2024 |
|
|
|
| Accumulated amortisation | |||
| At 01 January 2024 |
|
|
|
| Charge for the financial period |
|
|
|
| At 31 December 2024 |
|
|
|
| Net book value | |||
| At 31 December 2024 |
|
|
| 2024 | |
| £ | |
| Subsidiary undertakings |
|
Investments in subsidiaries
| 2024 | |
| £ | |
| Cost | |
| At 01 January 2024 | 0 |
| Additions |
|
| At 31 December 2024 |
|
| Carrying value at 31 December 2024 |
|
Investments in shares
The following were investment in shares of the Company:
| Name of entity | Registered office | Principal activity | Class of shares |
Ownership 31.12.2024 |
|
|
C/O Francis Clark Llp 23 Melville Building East, Royal William Yard, Plymouth, PL1 3GW | Domiciliary care |
|
|
| 2024 | |
| £ | |
| Amounts owed by Group undertakings |
|
| 2024 | |
| £ | |
| Amounts owed to directors |
|
| Accruals |
|
| Other creditors |
|
|
|
| 2024 | |
| £ | |
| Allotted, called-up and fully-paid | |
|
|
|
|
|
|
| 1.39 |
On 17 September 2024, the 1 Ordinary share of £1.00 was subdivided into 200 Ordinary shares of £0.005 each and reclassified as 200 Ordinary A shares of £0.005 each. On the same date, the company allotted 9,800 Ordinary B shares of £0.00004 each, fully paid.
As at the reporting date, the issued share capital of the company was as detailed above.